Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878).

× No keyword cloud information.

32 in total

Review 1. Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens.

Authors: W Hiddemann
Journal: Ann Hematol Date: 1991-04 Impact factor: 3.673

2. Synthesis and tumour-localizing properties of [18F]-5-fluorocytosine-arabinoside and [18F]-5-fluorocyclocytidine.

Authors: G W Visser; O Zwaagstra; G C Gorree; P Moonen; J D Herscheid; A Hoekstra
Journal: Eur J Nucl Med Date: 1986

3. Pharmacodynamic and DNA methylation studies of high-dose 1-beta-D-arabinofuranosyl cytosine before and after in vivo 5-azacytidine treatment in pediatric patients with refractory acute lymphocytic leukemia.

Authors: V I Avramis; R A Mecum; J Nyce; D A Steele; J S Holcenberg
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

Review 4. Clinical pharmacokinetics of cytarabine formulations.

Authors: Akinobu Hamada; Takeo Kawaguchi; Masahiro Nakano
Journal: Clin Pharmacokinet Date: 2002 Impact factor: 6.447

5. Pharmacodynamic modeling of chemotherapeutic effects: application of a transit compartment model to characterize methotrexate effects in vitro.

Authors: Evelyn D Lobo; Joseph P Balthasar
Journal: AAPS PharmSci Date: 2002

6. An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.

Authors: Kurt A Jaeckle; Tracy Batchelor; Steven J O'Day; Surasak Phuphanich; Pamela New; Glenn Lesser; Allen Cohn; Mark Gilbert; Robert Aiken; Deborah Heros; Lisa Rogers; Eric Wong; Dorcas Fulton; John C Gutheil; Said Baidas; Julia M Kennedy; Warren Mason; Paul Moots; Christy Russell; Lode J Swinnen; Stephen B Howell
Journal: J Neurooncol Date: 2002-05 Impact factor: 4.130

7. Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay.

Authors: R Ludwig; D S Alberts; T P Miller; S E Salmon
Journal: Cancer Chemother Pharmacol Date: 1984 Impact factor: 3.333

8. Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions.

Authors: S B Howell; B B Chu; W E Wung; B M Metha; J Mendelsohn
Journal: J Clin Invest Date: 1981-04 Impact factor: 14.808

9. Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.

Authors: J A Streifel; S B Howell
Journal: Proc Natl Acad Sci U S A Date: 1981-08 Impact factor: 11.205

10. Chemical synthesis of DNA oligomers containing cytosine arabinoside.

Authors: G P Beardsley; T Mikita; M M Klaus; A L Nussbaum
Journal: Nucleic Acids Res Date: 1988-10-11 Impact factor: 16.971